Lipoprotein (a) is a low-density lipoprotein that transports cholesterol in the blood. The lipoprotein (a) test — or Lp(a) test — determines the level of this lipoprotein in the blood, and its results ...

As part of "heart health month," we're looking at lipoprotein (a). For decades, doctors have encouraged patients to monitor their cholesterol levels, with studies showing that heart disease risk ...

Lipoprotein(a), or Lp(a), is a lesser-known cholesterol linked to a higher risk of heart attack and stroke. Cardiologists ...

Please provide your email address to receive an email when new articles are posted on . This installment of Pipeline Pulse focuses on a single cardiovascular risk ...

Lipoprotein(a) has been studied as a risk factor for coronary heart disease, but whether a causal relationship exists has been unclear. A study by Kamstrup and colleagues examining genetically ...

Please provide your email address to receive an email when new articles are posted on . Lipoprotein(a) is a genetic risk factor for CVD, for which there are no treatments currently available. A single ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--The Lipoprotein(a) Foundation announced the Centers for Disease Control and Prevention (CDC) has approved two ICD-10 codes for the diagnosis of elevated ...

All sex, race, and risk category groups appeared to be affected by the heart disease risk posed by elevated lipoprotein(a), or Lp(a), according to pooled analysis of primary prevention studies.

Lipoprotein(a) is a presumed risk factor for atherosclerotic cardiovascular disease. Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver. We conducted a randomized, ...

New Delhi: India accounts for around one-fifth of the deaths caused by cardiovascular disease (CVD), which is nearly 18 million lives globally each year. This is larger than all cancers combined. What ...